3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
4
Myeloproliferative Disorders
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia
2
Congenital Abnormalities
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Interventions
Cyclophosphamide
8
fludarabine phosphate
7
tagraxofusp
6
venetoclax
5
fludarabine
5
Whole-Body Irradiation
4
Mycophenolic Acid
4
Methotrexate
4
Thiotepa
3
Dexamethasone
3
Cytarabine
3
Cyclosporine
3
Calcium Dobesilate
3
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Vincristine
2
Tacrolimus
2
Specimen Handling
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Cyclosporins
2
Azacitidine
2
relmapirazin
1
prednylidene
1
lorvotuzumab mertansine
1
exifone
1
deltacortene
1
azathiopurine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm
×
Drug Therapy
×
Myeloid
×
Clear all
NCT03599960
2024-02-08
LpDessai
Centre Hospitalier Universitaire de Besancon
Phase 2
Unknown
26 enrolled